tirzepatide

Product

Last mentioned: 2d ago

Stories mentioning tirzepatide 2

pharma Bearish

Eli Lilly Warns of Impurities in Compounded Tirzepatide Amid Supply Shortage

Eli Lilly has identified hazardous impurities in unapproved, compounded versions of its blockbuster weight-loss drugs, Mounjaro and Zepbound. The pharmaceutical giant is warning patients and providers about significant safety risks as compounding pharmacies continue to exploit ongoing supply shortages.

3d ago 2 sources

pharma Bullish

Eli Lilly and Veeva Lead 2026 Growth Outlook Amid AI-Driven Pharma Shift

As market volatility persists in early 2026, Eli Lilly and Veeva Systems emerge as top growth picks driven by the obesity drug boom and AI integration. With Eli Lilly's tirzepatide securing its spot as the world's top-selling drug and new oral GLP-1s on the horizon, the pharmaceutical landscape is shifting toward tech-heavy, high-margin innovation.

Mar 4, 2026 2 sources